GlassScriptPhysician profile
Marlon R Brooks
NPI 1346278587
$4,057.81
in general payments reported to CMS, 2019-2025
19 companies · $1,762 in 2025
The $1,762 reported for 2025 was more than what 81% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $846 · 2020: $130 · 2021: $129 · 2022: $176 · 2023: $154 · 2024: $861 · 2025: $1,762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,200 · Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,200.00 |
| Food and Beverage | $576.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $2,200.00 | 2024-2025 | Bovine Collagen |
| Minerva Surgical, INC | $601.05 | 2019-2020 | |
| Exeltis, USA INC. | $197.23 | 2021-2025 | Slynd, Solosec |
| Boston Scientific Corporation | $196.68 | 2022-2025 | Bulkamid, Upsylon, Solyx Sis System |
| Abbvie INC. | $134.93 | 2019-2021 | |
| Olympus Corporation of The Americas | $120.22 | 2019 | |
| Organon LLC | $110.81 | 2024 | |
| Hologic Sales and Service, LLC | $103.69 | 2021-2023 | Thinprep 2000 Processor, Aptima |
| Sumitomo Pharma America, INC. | $86.44 | 2025 | Gemtesa |
| Therapeuticsmd, INC. | $53.56 | 2019-2022 | |
| Intuitive Surgical, INC. | $51.50 | 2021 | |
| Olympus America INC. | $46.72 | 2019 | |
| Astellas Pharma US INC | $34.77 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $24.95 | 2019 | |
| Channel Medsystems, INC. | $23.65 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $22.72 | 2019 | |
| Shield Therapeutics INC | $22.08 | 2024 | |
| Coopersurgical, INC. | $13.53 | 2019 | |
| Aspira Women'S Health INC | $13.28 | 2023 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlon Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.